|1.||Donald, Peter R: 2 articles (04/2012 - 01/2006)|
|2.||Schaaf, H Simon: 2 articles (04/2012 - 01/2006)|
|3.||Starke, Jeffrey R: 2 articles (04/2012 - 07/2011)|
|4.||Schutte, C M: 2 articles (08/2001 - 01/2000)|
|5.||Shinjo, Ryuichi: 1 article (11/2015)|
|6.||Matsuyama, Yukihiro: 1 article (11/2015)|
|7.||Hida, Tetsuro: 1 article (11/2015)|
|8.||Ito, Zenya: 1 article (11/2015)|
|9.||Ishiguro, Naoki: 1 article (11/2015)|
|10.||Kobayashi, Kazuyoshi: 1 article (11/2015)|
01/01/2015 - "Cases of TB meningitis, nosocomial, postoperative and other nonbacterial meningitis were excluded. "
05/01/2011 - "neoformans or TB meningitis and HIV chronic meningitis: CSF LA can be included with the methods currently used to identify these specific pathogens, though it does not replace them. "
05/01/2011 - "CSF LA (median; IQR) was higher in samples with TB meningitis (5.5; 2.9-7.5 mmol/L) and Cryptococcus neoformans meningitis (3.9; 2.7-5.8 mmol/L) compated with samples with HIV chronic meningitis (1.7; 1.4-1.9 mmol/L) and other groups (p ≤ 0.0001). "
01/01/2002 - "TB meningitis in the 0-4 years group showed a significantly more pronounced decline than that of adults TB for the period 1980-2000, (only 10 meningitis cases were diagnosed in year 2000, 0.29/100,000), confirming the protection conferred by BCG vaccination when applied to newborns with a continuously high coverage."
03/01/2000 - "Nine patients were in stage I meningitis, 12 in stage II, and 33 in stage III. On single variable logistic regression analysis the significant predictors of 6 months outcome of TB meningitis included focal weakness, Glasgow coma scale (GCS), motor evoked potential (MEP) and somatosensory evoked potential (SEP). "
|2.||Acquired Immunodeficiency Syndrome (AIDS)
02/01/2013 - "All five studies found improved AIDS-free survival with earlier ART initiation in TB patients with low CD4 T-cell counts, except among patients with TB meningitis. "
01/01/1999 - "Furthermore, the cure rates of the patients attained--in average--only 60.0% and several warning indicators (IA)--like TB meningitis cases and mortality due to TB in people younger than thirty years old, as well as TB--HIV/AIDS association--have been observed to grow in several districts. "
04/01/2015 - "Two patients died: a 38-year-old woman with human immunodeficiency virus/acquired immune deficiency syndrome and TB meningitis without TDM, and a 76-year-old man with fluoroquinolone-resistant (pre-extensively drug-resistant) pulmonary TB and low linezolid and capreomycin concentrations. "
06/01/2006 - "Whilst infection due to most causes decreased, the incidence of tuberculous (TB) meningitis doubled over the 12 years. "
01/01/2012 - "It is imperative to be aware of the key clinical features of TB meningitis, and maintain a high level of suspicion when dealing with CNS infection if the cause is unknown."
03/01/2009 - "Reported TB incidence data (1974-2002), previously published TB meningitis data from the pre-chemotherapy era, and previous estimates of disease risk following infection were used to estimate a trend in the annual risk of infection from 1929 to 2002, and the age-specific prevalence of infection in 2002. "
12/01/2001 - "Most important is the recognition that bacterial antigen testing for the diagnosis of acute bacterial meningitis rarely impacts patient management and is not routinely needed, CSF shunt infections differ from usual meningeal infections and require rapid diagnosis, and TB meningitis remains a difficult disease to diagnosis but may be confirmed first by PCR testing of CSF. "
|5.||Herpes Simplex Encephalitis (Herpes Encephalitis)
09/01/2003 - "The causes of death were intra-cranial haemorrhage on day +7, herpes encephalitis on day +180, graft failure and mucour mycosis on day +353 and TB meningitis on day +544. "
10/01/2006 - "False positive results were observed in 7 of the 59 patients (11.8%) with non-TB meningitis, (patients with herpetic meningoencephalitis and meningitis due to intracellular microorganisms). "
|1.||Interferon-alpha (Interferon Alfa)
|5.||Adrenal Cortex Hormones (Corticosteroids)
|9.||butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB)
|3.||Drug Therapy (Chemotherapy)